Author:
Guo Lin-Feng,Rao Ming-Yue,Yu Yi-Feng,Lin Qin,Wu San-Gang
Funder
Xiamen Medical and Health Guidance Project
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Zhang Y, Rumgay H, Li M, Cao S, Chen W. Nasopharyngeal Cancer incidence and mortality in 185 countries in 2020 and the projected Burden in 2040: Population-based global epidemiological profiling. JMIR Public Health Surveill. 2023;9:e49968.
2. Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 201736(1):90.
3. Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
4. Chen YP, Ismaila N, Chua MLK, Colevas AD, Haddad R, Huang SH, et al. Chemotherapy in Combination with Radiotherapy for definitive-intent treatment of stage II-IVA nasopharyngeal carcinoma: CSCO and ASCO Guideline. J Clin Oncol. 2021;39(7):840–59.
5. Ng WT, Corry J, Langendijk JA, Lee AWM, Mäkitie A, Mendenhall WM, et al. Current management of stage IV nasopharyngeal carcinoma without distant metastasis. Cancer Treat Rev. 2020;85:101995.